MedTrace Logo

The Austrian LEAD (Lung hEart sociAl boDy) Study

NCT01727518 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 14966

Last updated 2024-12-17

Study results available
· View outcomes & findings →

Summary

The LEAD study is the first longitudinal cohort investigating respiratory, cardiac, and metabolic health in a reference population of Austria.

Conditions

  • Respiration Disorders
  • Body Composition, Beneficial
  • Metabolic Health

Interventions

OTHER

As the LEAD study is an observational cohort study, there is no intervention to report.

As the LEAD study is an observational cohort study, there is no intervention to report.

Sponsors & Collaborators

  • Ludwig Boltzmann Institute for Lung Health

    lead OTHER

Principal Investigators

  • Robab Breyer-Kohansal, Prof. Dr. · Ludwig Boltzmann Institute for Lung Health, Vienna, Austria

  • Marie-Kathrin Breyer, Prof. Dr · Ludwig Boltzmann Institute for Lung Health, Vienna, Austria

Eligibility

Min Age
6 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2016-10-31
Completion
2028-10-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01727518 on ClinicalTrials.gov